Satsuma Pharmaceuticals, Inc. ( NASDAQ:STSA – Get Rating ) Director Ken Takanashi acquired 22,053,581 shares of Satsuma Pharmaceuticals stock in a transaction dated Tuesday, June 6th. The shares were purchased at an average price of $0.91 per share, with a total value of $20,068,758.71. Following the acquisition, the director now owns 24,847,694 shares of the company's stock, valued at $22,611,401.54. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink .

https://www.dailypolitical.com/2023/06/08/satsuma-pharmaceuticals-inc-nasdaqstsa-director-ken-takanashi-buys-22053581-shares.html

#dailypolitical